Search

Search Constraints

You searched for: Author/Creator Kata, D

Search Results

1. Erratum to: P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease. (7th October 2021)

4. P371 Outcome of immediate infliximab optimisation based on rapid assessment of serum drug and faecal calprotectin concentrations in Crohn's disease. (25th January 2019)

5. P444 COVID-19 risk factors, infection course and vaccination among patients with inflammatory bowel disease based on a Hungarian cohort. (21st January 2022)

8. P463 Serum and mucosal Serpin E1 concentration correlates with endoscopic activity in inflammatory bowel disease - potential new activity marker. (21st January 2022)

9. P495 Does drug level monitoring help us to understand the mechanism behind the superiority of combo therapy in inflammatory bowel diseases?. (16th January 2018)

10. P654 Advances in optimalisation of therapeutic drug monitoring using mucosal TNF expression and anti-TNF concentration in patients with inflammatory bowel disease treated with biologicals: Preliminary results from a single-centre study. (16th January 2018)